Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351Mélanie Donnette, Raphaëlle Fanciullino, Bruno Lacarelle et al.|Journal of Controlled Release|2021Cited by 9
Cytidine deaminase status as a marker of response to azacytidine treatment in <scp>MDS</scp> and <scp>AML</scp> patientsMélanie Donnette, Raphaëlle Fanciullino, Mourad Hamimed et al.|British Journal of Haematology|2023Cited by 4
Cytidine deaminase activity predicts clinical outcome of azacitidine in real-world MDS patientsMélanie Donnette, Raphaëlle Fanciullino, Geoffroy Venton et al.|Research Square|2022Cited by 0